Effects of Three Types of Dual-task Interventions on Dual-task Walking Performance of Stroke Patients
Immediate and Retained Effects of Three Types of Dual-task Interventions on Dual-task Walking Performance of Stroke Patients: Psychometric Study and Randomized Controlled Trial
1 other identifier
interventional
54
1 country
1
Brief Summary
The objective of this study is to investigate psychometric properties of dual-task walking assessments and compare effects of three types of dual-task balance interventions on dual-task walking for stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Oct 2018
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2018
CompletedFirst Posted
Study publicly available on registry
August 3, 2018
CompletedStudy Start
First participant enrolled
October 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedAugust 2, 2022
July 1, 2022
3.2 years
July 31, 2018
July 31, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
gait speed
Participants will walk 10m at their preferred speed and at fast speed. A 12-meter walkway will be used for walking testing. In order to allow the subjects to have enough distance to accelerate and decelerate, only the time taken to walk the middle 10 meters will be recorded by a stopwatch. The primary gait parameter is gait speed (cm/s) under dual-task walking conditions using the 10 Meter Walking Test.
10 minutes
composite score
For all the cognitive tasks, we will calculate a composite score for cognitive-task performance by dividing the accuracy (% correct responses) with the reaction time of correct answers (milliseconds), which accounts for speed-accuracy tradeoffs in the overall dual-task effect.
10 minutes
Secondary Outcomes (8)
Berg Balance Scale (BBS).
5-10 minutes
Mini-Balance Evaluation Systems Test (Mini-BESTest).
10 minutes
Timed Up and Go Test (TUG)
2 minutes
Functional Gait Assessment (FGA).
10 minutes
Activity-specific Balance Confidence Scale (ABC).
2 minutes
- +3 more secondary outcomes
Study Arms (3)
MCDTT
EXPERIMENTALThe MCDTT group will receive dual-task interventions at progressively increasing task difficulty 3 times a week for 4 weeks.
MDTT
ACTIVE COMPARATORThe MDTT group will receive dual-task interventions at progressively increasing task difficulty 3 times a week for 4 weeks.
CDTT
ACTIVE COMPARATORThe CDTT group will receive dual-task interventions at progressively increasing task difficulty 3 times a week for 4 weeks.
Interventions
The MCDTT group will undertake sitting to standing, standing balance, and treadmill walking training while concurrently perform motor and cognitive tasks.
The MDTT group will train the same set of sitting to standing, standing balance, and walking activities as the MCDTT group while simultaneously performing only motor task.
The CDTT group will train the same set of sitting to standing, standing balance, and walking activities as the MCDTT group while simultaneously performing only cognitive task.
Eligibility Criteria
You may qualify if:
- (1) first-ever stroke with onset duration more than 3 months
- (2) able to walk 10 m
- (3) no severe vision, hearing, and language problems.
You may not qualify if:
- orthopedic and other neurological disorders that affect walking
- other treatments that could influence the effects of the interventions (e.g., recent Botulin toxin treatment of the lower extremity)
- moderate or severe cognitive impairments (score \< 24 on Mini-Mental State Examination)
- severe uncorrected visual deficits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung University
Taoyuan District, 333, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 31, 2018
First Posted
August 3, 2018
Study Start
October 24, 2018
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
August 2, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share